FDA is involved in regulatory pathways utilizing Australian trial sites, including Alfred Health, Royal Adelaide Hospital, and Mackay Base Hospital.
1 report, 1 independent
Updated Jul 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA is involved in regulatory pathways utilizing Australian trial sites, including Alfred Health, Royal Adelaide Hospital, and Mackay Base Hospital.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Alfred Health
healthcare organization in Melbourne, Australia
Related events
- BioPorto is seeking regulatory pathways and activating its first clinical site in collaboration with Massachusetts General Hospital.
- The FDA operates under US law to evaluate international clinical data.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- Ondine Biomedical Inc. is seeking a pre-NDA meeting with the FDA regarding LANTERN results while conducting clinical trials in the US and Canada.
- Fate Therapeutics, based in San Diego, is seeking support for an accelerated regulatory pathway from the FDA.